CCFM
BIOTW

Cohen & Co Financial Management’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Cohen & Co Financial Management’s Portfolio BIOTW Stock Details BIOTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50,000
Closed -$33K – 129
2021
Q4 		$33K Buy
+50,000
New +$34.7K 0.02% 98

Other funds holding BIOTW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Cohen & Co Financial Management's BIOTW Position: Q1 2022 in Review

Cohen & Co Financial Management sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2022, closing a stake of 50,000 shares — an estimated $33K sold.

Cohen & Co Financial Management first reported a position in BIOTW in Q4 2021 and held it in 1 quarter. The position peaked at $33K in Q4 2021. 52 funds tracked by Wall St. Rank hold BIOTW as of Q1 2022.

  • Cohen & Co Financial Management reported no remaining Biotech Acquisition Company Warrant position as of Q1 2022 after selling out during the quarter.
  • Cohen & Co Financial Management sold 50,000 Biotech Acquisition Company Warrant shares in Q1 2022, an estimated $33K.
  • Cohen & Co Financial Management first reported a position in Biotech Acquisition Company Warrant in Q4 2021 and held it in 1 quarter.
  • Cohen & Co Financial Management's Biotech Acquisition Company Warrant position peaked at $33K in Q4 2021.
  • 52 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2022.

Based on Cohen & Co Financial Management's 13F filing for Q1 2022, filed 16 May 2022.